reversible inhibitors targeting MAO-B is still a desirable line of therapeutic research. Within this framework, a small library of chromone derivatives was synthesized and screened towards human monoamine oxidases. Structural modifications on the chromone 3-phenylcarboxamide resulted in potent MAO-B inhibitors with an improved drug-like profile, and for the first time we obtained potent and selective chromone
帕
金森病治疗中缺乏改善疾病的药物促使新的
化学实体作用于相关的 PD 相关
生物靶点。因此,开发靶向 MAO-B 的选择性和可逆
抑制剂仍然是治疗研究的理想方向。在这个框架内,合成了一个小的
色酮衍
生物库,并针对人类单胺氧化酶进行了筛选。
色酮 3-苯基甲酰胺的结构修饰产生了有效的 MAO-B
抑制剂,具有改善的药物样特性,并且我们首次获得了在低纳摩尔范围内起作用的强效和选择性
色酮 2-苯基甲酰胺。化合物 5-hydroxy-4-oxo- N -phenyl-4H-chromene-3-carboxamide ( 38 ) (IC 50 = 13.0 nM) 和N-(4-chlorophenyl)-5-hydroxy-4-oxo-4H-chromene-3-carboxamide ( 41 ) (IC 50 = 8.3 nM) 作为可逆、有效、选择性和非细胞毒性 MAO-B
抑制剂脱颖而出有利的药物样配置文件。两种化合物都显示出对
铁